New developments in the neurobiology of the tuberous sclerosis complex

Gomez MR. Tuberous sclerosis. New York:Raven Press 1988.

O’Callaghan FJ, Shiell AW, Osborne JP, Martyn CN. Prevalence of tuberous sclerosis estimated by capture-recapture analysis. Lancet 1998;351:1490.

10.1111/j.1750-3639.1995.tb00591.x

Bourneville DM. Contributions a l’etude de l’idiotie. III. Sclerose tuberoeuse des circonvolutions cerebrales. Arch Int Neurol 1880;1:81–91.

von Recklinghausen FD. Ein Herz von einen Neurogeborenen. Verb Berl Ges Geburt 1863;15:73.

Roach ES, Smith M, Huttenlocher P, Bhat M, Alcorn D, Hawley L. Diagnostic criteria: tuberous sclerosis complex. J Child Neurol 1992;2:221–224.

10.1177/088307389801301206

10.1016/0030-4220(91)90523-F

10.1016/0092-8674(93)90618-Z

10.1126/science.277.5327.805

10.1111/j.1469-1809.1994.tb01881.x

10.1093/hmg/5.2.249

Au K-S, Rodriguez J, Finch J, et al. Germ-line mutational analysis of the TSC2 gene in 90 tuberous sclerosis patients. Am J Hum Genet 1997;62:286–294.

10.1093/hmg/6.9.1409

10.1093/hmg/6.11.1991

10.1136/jmg.36.4.285

10.1093/hmg/6.12.2155

10.1086/302381

10.1086/302412

10.1111/j.1749-6632.1991.tb37755.x

10.1007/BF00315012

10.1007/s004010050438

Wiestler O Lopez B Crino PB. Tuberous sclerosis complex and subependymal astrocytoma. In: Kleihues P Cavenee WK eds. Pathology and genetics: tumors of the nervous system. Lyon:International Agency for Research on Cancer 1997:182–185.

10.1073/pnas.93.24.14152

10.1007/BF01403693

Tien RD, Hesselink JR, Duberg A. Rare subependymal giant cell astrocytoma in a neonate with tuberous sclerosis. AJNR Am J Neuroradiol 1990;11:1251–1252.

Gyure KA, Prayson RA. Subependymal giant cell astrocytoma: a clinicopathologic study with HMB45 and MIB-1 immunohistochemical analysis. Mod Pathol 1997;10:313–317.

10.1073/pnas.91.24.11413

Yeung RS, Katsetos CD, Klein-Szanto A. Subependymal astrocytic hamartomas in the Eker rat model of tuberous sclerosis. Am J Pathol 1997;151:1477–1486.

10.1093/hmg/7.6.1053

Geist R, Gutmann D. The tuberous sclerosis 2 gene is expressed at high levels in the cerebellum and developing spinal cord. Cell Growth Differentiation 1995;6:1477–1483.

10.1006/nbdi.1996.0011

Wienecke R, Maize J, Reed J, deGunzburg J, Yeung R, DeClue J. Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues. Am J Pathol 1997;150:43–50.

10.1111/j.1750-3639.1996.tb00866.x

10.1002/ana.410400621

Plank TL, Yeung RS, Henske EP. Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles. Cancer Res 1998;58:4766–4770.

10.1074/jbc.270.27.16409

Wienecke R, Maize J, Shoarinejad F, et al. Co-localization of the TSC2 product tuberin with its target Rap1 in the Golgi apparatus. Oncogene 1996;13:913–923.

10.1074/jbc.272.46.29301

10.1038/sj.onc.1201743

10.1074/jbc.272.10.6097

10.1074/jbc.273.32.20535

10.1073/pnas.93.17.9154

10.1002/gcc.2870130411

10.1093/hmg/3.10.1829

10.1038/ng0294-193

Henske E, Scheithauer B, Short M, et al. Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am J Hum Genet 1996;59:400–406.

Henske E, Wessner L, Golden J, et al. Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors. Am J Pathol 1997;151:1639–1647.

10.1007/s004010050587

10.1016/0896-6273(95)90035-7

Walsh C, Cepko CL. Clonal dispersion in proliferative layers of developing cerebral cortex. Nature 1993;15:299–310.

Padmalatha C, Harruff R, Ganick D, Hafez G. Glioblastoma multiforme with tuberous sclerosis. Report of a case. Arch Pathol Lab Med 1980;104:649–650.

10.1038/sj.onc.1201314

10.1002/ana.410420215

10.1007/s004010050691

10.1006/geno.1997.4659

10.1016/S0887-8994(97)00036-2

10.1002/ana.410090211

10.1111/j.1749-6632.1991.tb37756.x

10.1002/ana.410160511

10.1007/BF00334458

10.1016/0014-4886(91)90007-Y

10.1097/00005072-199509000-00011